Literature DB >> 26880764

A Heterozygous RAB27A Mutation Associated with Delayed Cytolytic Granule Polarization and Hemophagocytic Lymphohistiocytosis.

Mingce Zhang1, Claudia Bracaglia2, Giusi Prencipe2, Christina J Bemrich-Stolz3, Timothy Beukelman4, Reed A Dimmitt5, W Winn Chatham6, Kejian Zhang7, Hao Li6, Mark R Walter8, Fabrizio De Benedetti2, Alexei A Grom9, Randy Q Cron10.   

Abstract

Frequently fatal, primary hemophagocytic lymphohistiocytosis (HLH) occurs in infancy resulting from homozygous mutations in NK and CD8 T cell cytolytic pathway genes. Secondary HLH presents after infancy and may be associated with heterozygous mutations in HLH genes. We report two unrelated teenagers with HLH and an identical heterozygous RAB27A mutation (c.259G→C). We explore the contribution of this Rab27A missense (p.A87P) mutation on NK cell cytolytic function by cloning it into a lentiviral expression vector prior to introduction into the human NK-92 cell line. NK cell degranulation (CD107a expression), target cell conjugation, and K562 target cell lysis was compared between mutant- and wild-type-transduced NK-92 cells. Polarization of granzyme B to the immunologic synapse and interaction of mutant Rab27A (p.A87P) with Munc13-4 were explored by confocal microscopy and proximity ligation assay, respectively. Overexpression of the RAB27A mutation had no effect on cell conjugate formation between the NK and target cells but decreased NK cell cytolytic activity and degranulation. Moreover, the mutant Rab27A protein decreased binding to Munc13-4 and delayed granzyme B polarization toward the immunologic synapse. This heterozygous RAB27A mutation blurs the genetic distinction between primary and secondary HLH by contributing to HLH via a partial dominant-negative effect.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26880764      PMCID: PMC4779709          DOI: 10.4049/jimmunol.1501284

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  Efficient in vivo targeting of epidermal stem cells by early gestational intraamniotic injection of lentiviral vector driven by the keratin 5 promoter.

Authors:  Masayuki Endo; Philip W Zoltick; William H Peranteau; Antoneta Radu; Nidal Muvarak; Mayumi Ito; Zaixin Yang; George Cotsarelis; Alan W Flake
Journal:  Mol Ther       Date:  2007-10-09       Impact factor: 11.454

3.  Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome.

Authors:  Philip J Kahn; Randy Q Cron
Journal:  J Rheumatol       Date:  2013-05       Impact factor: 4.666

4.  Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A.

Authors:  Udo Zur Stadt; Karin Beutel; Susanne Kolberg; Reinhard Schneppenheim; Hartmut Kabisch; Gritta Janka; Hans Christian Hennies
Journal:  Hum Mutat       Date:  2006-01       Impact factor: 4.878

5.  A case of macrophage activation syndrome successfully treated with anakinra.

Authors:  Alison Kelly; Athimalaipet V Ramanan
Journal:  Nat Clin Pract Rheumatol       Date:  2008-09-30

Review 6.  Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell?

Authors:  Edward M Behrens
Journal:  Autoimmun Rev       Date:  2008-01-04       Impact factor: 9.754

7.  Structural basis for the exclusive specificity of Slac2-a/melanophilin for the Rab27 GTPases.

Authors:  Mutsuko Kukimoto-Niino; Ayako Sakamoto; Eiko Kanno; Kyoko Hanawa-Suetsugu; Takaho Terada; Mikako Shirouzu; Mitsunori Fukuda; Shigeyuki Yokoyama
Journal:  Structure       Date:  2008-10-08       Impact factor: 5.006

8.  Elucidation of Rab27 recruitment by its effectors: structure of Rab27a bound to Exophilin4/Slp2-a.

Authors:  Leonard M G Chavas; Kentaro Ihara; Masato Kawasaki; Seiji Torii; Tamami Uejima; Ryuichi Kato; Tetsuro Izumi; Soichi Wakatsuki
Journal:  Structure       Date:  2008-10-08       Impact factor: 5.006

9.  Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis.

Authors:  Melissa M Hazen; Amy L Woodward; Inga Hofmann; Barbara A Degar; Alexei Grom; Alexandra H Filipovich; Bryce A Binstadt
Journal:  Arthritis Rheum       Date:  2008-02

10.  Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms.

Authors:  Kejian Zhang; Jennifer Biroschak; David N Glass; Susan D Thompson; Terri Finkel; Murray H Passo; Bryce A Binstadt; Alexandra Filipovich; Alexei A Grom
Journal:  Arthritis Rheum       Date:  2008-09
View more
  23 in total

1.  Brief Report: Novel UNC13D Intronic Variant Disrupting an NF-κB Enhancer in a Patient With Recurrent Macrophage Activation Syndrome and Systemic Juvenile Idiopathic Arthritis.

Authors:  Grant S Schulert; Mingce Zhang; Ammar Husami; Ndate Fall; Hermine Brunner; Kejian Zhang; Randy Q Cron; Alexei A Grom
Journal:  Arthritis Rheumatol       Date:  2018-05-02       Impact factor: 10.995

Review 2.  Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg.

Authors:  Courtney Crayne; Randy Q Cron
Journal:  Eur J Rheumatol       Date:  2019-12-03

Review 3.  Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.

Authors:  Lauren A Henderson; Randy Q Cron
Journal:  Paediatr Drugs       Date:  2020-02       Impact factor: 3.022

Review 4.  The genetics of macrophage activation syndrome.

Authors:  Grant S Schulert; Randy Q Cron
Journal:  Genes Immun       Date:  2020-04-15       Impact factor: 2.676

Review 5.  A research-driven approach to the identification of novel natural killer cell deficiencies affecting cytotoxic function.

Authors:  Michael T Lam; Emily M Mace; Jordan S Orange
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

Review 6.  Macrophage Activation Syndrome: different mechanisms leading to a one clinical syndrome.

Authors:  Claudia Bracaglia; Giusi Prencipe; Fabrizio De Benedetti
Journal:  Pediatr Rheumatol Online J       Date:  2017-01-17       Impact factor: 3.054

7.  Downregulation of Rab27A contributes to metformin-induced suppression of breast cancer stem cells.

Authors:  Feixue Feng; Jianping Zhang; Xiaoxuan Fan; Fang Yuan; Yinghao Jiang; Ruihua Lv; Yanxia Ma
Journal:  Oncol Lett       Date:  2017-07-08       Impact factor: 2.967

Review 8.  The Immunology of Macrophage Activation Syndrome.

Authors:  Courtney B Crayne; Sabrin Albeituni; Kim E Nichols; Randy Q Cron
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

9.  FHLdb: A Comprehensive Database on the Molecular Basis of Familial Hemophagocytic Lymphohistiocytosis.

Authors:  Laura Viñas-Giménez; Natàlia Padilla; Laura Batlle-Masó; Ferran Casals; Jacques G Rivière; Mónica Martínez-Gallo; Xavier de la Cruz; Roger Colobran
Journal:  Front Immunol       Date:  2020-01-31       Impact factor: 7.561

10.  ADAP Promotes Degranulation and Migration of NK Cells Primed During in vivo Listeria monocytogenes Infection in Mice.

Authors:  Martha A L Böning; Stephanie Trittel; Peggy Riese; Marco van Ham; Maxi Heyner; Martin Voss; Gerald P Parzmair; Frank Klawonn; Andreas Jeron; Carlos A Guzman; Lothar Jänsch; Burkhart Schraven; Annegret Reinhold; Dunja Bruder
Journal:  Front Immunol       Date:  2020-01-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.